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A Multifunctional Polymeric Periodontal Membrane 
with Osteogenic and Antibacterial Characteristics
Amir Nasajpour, Sahar Ansari, Chiara Rinoldi, Afsaneh Shahrokhi Rad, Tara Aghaloo, 
Su Ryon Shin, Yogendra Kumar Mishra, Rainer Adelung, Wojciech Swieszkowski, 
Nasim Annabi, Ali Khademhosseini, Alireza Moshaverinia,* and Ali Tamayol*
Periodontitis is a prevalent chronic, destructive inflammatory disease 
affecting tooth-supporting tissues in humans. Guided tissue regeneration 
strategies are widely utilized for periodontal tissue regeneration generally 
by using a periodontal membrane. The main role of these membranes is 
to establish a mechanical barrier that prevents the apical migration of the 
gingival epithelium and hence allowing the growth of periodontal liga-
ment and bone tissue to selectively repopulate the root surface. Currently 
available membranes have limited bioactivity and regeneration potential. 
To address such challenges, an osteoconductive, antibacterial, and flex-
ible poly(caprolactone) (PCL) composite membrane containing zinc oxide 
(ZnO) nanoparticles is developed. The membranes are fabricated through 
electrospinning of PCL and ZnO particles. The physical properties, mechan-
ical characteristics, and in vitro degradation of the engineered membrane are 
studied in detail. Also, the osteoconductivity and antibacterial properties of 
the developed membrane are analyzed in vitro. Moreover, the functionality of 
the membrane is evaluated with a rat periodontal defect model. The results 
confirmed that the engineered membrane exerts both osteoconductive and 
antibacterial properties, demonstrating its great potential for periodontal 
tissue engineering.
DOI: 10.1002/adfm.201703437
1. Introduction
Periodontitis is a chronic destructive 
inflammatory disease, which is one of 
the most prevalent chronic infections in 
humans.[1] Periodontal disease leads to the 
destruction of the periodontium including 
alveolar bone, the periodontal ligament 
(PDL), and root cementum.[1,2] If improp­
erly treated, periodontitis will result in 
progressive periodontal bone loss that 
may eventually lead to early tooth loss.[3] 
Approximately 35% of the adult human 
population globally suffers from a mod­
erate form of periodontitis, while a severe 
generalized form of periodontitis affects 
around 15% at some stage in their lives. 
Literature studies have shown that more 
than 47% of adults aged 30 years and 
older are diagnosed with some form of 
periodontal disease.[4] Furthermore, peri­
odontal disease increases with respect to 
age. More than 70% of adults aged 65 or 
older are diagnosed with some form of 
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periodontal disease. Data from the National Institute of Dental 
and Craniofacial Research has revealed that nearly 90% of 
adult populations older than 70 years present at least a mode­
rate level of periodontal­related diseases.[5] Once damaged, the 
periodontium has a limited capacity for regeneration. Effective 
treatment for periodontal disease is of utmost importance, as 
its consequences can eventually result in tooth loss.
The ultimate goal of periodontal therapy is the regenera­
tion of all the components of the periodontium. Over the past 
decade, several strategies for periodontal repairing, mainly 
based on conventional anti­infectious measures, guided tissue 
regeneration (GTR), or application of cytokines, growth factors, 
or bioactive molecules, have been followed.[6] However, the sys­
tematic reviews of the clinical outcomes of these procedures 
show inconsistencies in the results and variable responses.[7] 
The significantly high burden of the periodontal disease and its 
negative consequences on the patient’s quality of life indicate 
a strong need for more effective therapies. Tissue engineering 
provides a new concept for periodontal tissue regeneration 
through cell delivery to the damaged sites.[7] GTR strategies 
based on the use of periodontal membranes have been sug­
gested for periodontal regeneration.[8] The periodontal mem­
brane acts as a mechanical barrier which prevents or retards 
the apical migration of the gingival epithelium and allows 
periodontal ligament and bone tissue to selectively repopulate 
the root surface during healing. In addition, GTR membranes 
should maintain proper properties (e.g., flexibility and degrada­
tion profile) that allow for their usage in periodontal defect sites 
without premature collapsing within the defect site to prevent 
compromising the regenerative outcome.[9]
Currently, for GTR procedures both nonabsorbable and 
absorbable membranes are available.[5,10] The nonabsorb­
able membranes require a second surgery for their removal, 
which can compromise the newly formed tissues. On the other 
hand, existing biodegradable membranes have a lack of suit­
able mechanical properties and controlled degradation rate.[11] 
Other major drawbacks of the current periodontal membranes 
are low adhesion to the surrounding tissues, lack of antibacte­
rial properties, and inability to promote tissue regeneration.[12] 
For successful periodontal tissue regeneration, adhesion and 
retention of the membrane to the application site, as well as 
its regenerative properties, are considered crucial factors. Cur­
rently, there is an unmet need for the development of novel 
biodegradable periodontal membranes, which support adhe­
sion to surrounding tissues, minimize bacterial activity, and 
induce osteodifferentiation. Electrospun membranes mimic 
the microenvironment found within the extracellular matrix 
and support cellular growth. Electrospun membranes are sutur­
able and typically flexible, the small pore size could effectively 
prevent the migration of cells across the membrane barrier.[13] 
Thus, they could represent an ideal candidate for GTR.
In this study, we have developed and characterized a flexible 
and biodegradable membrane for treatment of periodontitis via 
GTR, which could minimize bacterial infection and support 
osteogenesis. The membranes are electrospun with a dispersed 
solution of ZnO within a carrier polymer, poly(caprolactone) 
(PCL). The incorporation of ZnO particles not only introduces 
an antibacterial activity, but also improves the osteoconductivity 
of the periodontal membrane.[14] The biological and physical 
properties of the engineered scaffolds were also assessed. In 
addition to in vitro experiments, we implanted the engineered 
membrane in vivo to assess its functionality within a rat peri­
odontal defect model. The developed membrane provides an 
appropriate microenvironment to regulate the fate of the local 
progenitor stem cells toward osteogenic tissues for periodontal 
tissue regeneration.
2. Results and Discussions
PCL electrospun fibers have proven to be an excellent substrate 
for bone tissue engineering.[15] Due to PCL’s semi­crystalline 
nature, the degradation is slow and dependent on the polymer 
molecular weight.[16] To render the membranes antibacterial and 
osteoconductive, we incorporated ZnO particles into the fibrous 
membranes.[17] The membranes were fabricated by electrospin­
ning of 10% (w/v) PCL solution in hexafluoroisopropanol con­
taining 0, 0.5, and 1% (w/v) ZnO nanoparticles. The pertinent 
literature has reported that mixtures carrying less than 2% (w/v) 
ZnO do not show inhibitory effect on cellular growth, while 
concentrations above 0.5% (w/v) ZnO can offer antibacterial 
activity. Thus, we selected the proposed concentrations to assess 
their effectiveness in osteogenesis.[18] The nanoparticles were 
dispersed by sonication and intermittent vortexing. Figure 1a,b 
shows the fabrication process of the membrane and its appli­
cation for the treatment of periodontium disorders. The 
morphology of ZnO nanoparticles and the produced fibrous 
structures are shown in Figure 1c–e. The scanning elec­
tron microscope (SEM) data suggest that the particles were 
not monodisperse and their dimensions are in the range of 
50–200 nm. The membranes were made of randomly distributed 
nano/micrometer­sized fibers. The SEM images showed a rough­
ened fiber size after the incorporation of ZnO nanoparticles. 
The nanoparticle distribution was mapped within the PCL mats 
using dispersive X­ray microanalysis (energy­dispersive X­ray, 
EDX) coupled with SEM and the elemental atoms to decipher 
nanomaterials within the fibrous network. In the membrane 
composition map, zinc, oxygen, and carbon appeared in the 
colors aqua, green, and red, respectively (Figure 1e; Figure S1, 
Supporting Information). The morphological studies confirmed 
the uniform distribution of ZnO nanoparticles throughout the 
fabricated membranes as well as at the surface of the fibers.
The mechanical properties of the engineered membranes 
were assessed under uniaxial tensile testing and the meas­
ured values are reported in stress–strain graphics presented in 
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Figure 2a. The ultimate tensile strength, ultimate strain, and the 
tensile modulus were calculated from the stress–strain curves. 
The results suggested that the incorporation of ZnO particles 
reduced the ultimate strength of the engineered membranes 
(p < 0.01, Figure 2b). The ultimate strain, however, was not 
significantly changed following ZnO incorporation (Figure 2c). 
The incorporation of stiff ZnO particles may create cavities 
within the soft polymer network, but at the same time, higher 
Adv. Funct. Mater. 2018, 28, 1703437
Figure 1. Fabrication of ZnO-doped PCL composite membrane. a) ZnO spherical nanoparticles were embedded within poly(caprolactone) (PCL) and 
the membrane was fabricated via electrospinning. b) A representative SEM image of ZnO nanoparticles. c) High magnification of membranes con-
taining 1% (w/v) ZnO: the image of the membrane illustrates a rough surface due to incorporation of ZnO nanoparticles. d) EDAX elemental imaging 
of the membrane with 1% (w/v) ZnO. The aqua colour annotates the atom zinc found in the composite membrane. The image shows a uniform 
distribution of the spherical particles throughout the membrane.
Figure 2. Characterization of engineered membranes containing different amounts of ZnO nanoparticles. a) Representative uniaxial tensile stress–strain 
curves of electrospun membranes made from pristine PCL, PCL with ZnO 0.5% (w/v), and PCL with ZnO 1% (w/v) solutions. b–d) The mechanical properties 
obtained from the uniaxial tensile test for the membranes with different ZnO nanoparticle concentration including b) ultimate tensile stress values, c) ultimate 
strain, and d) Young’s Modulus. e,f) Degradation rate of the engineered membranes in e) artificial saliva (pH 7.4) and f) alkaline solution (pH 8.5). g,h) Water 
uptake of membranes after 2 and 24 h in g) artificial saliva (pH 7.4) and h) phosphate buffer solution (PBS) containing NaOH (pH 8.5). *: p < 0.05, **: p < 0.01.
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concentration of the particles improves the tensile modulus of 
the composite construct as reported in Figure 2d. This com­
petitive trend has been previously described for composites of 
polymeric systems doped with dispersed nanoparticles.[19] Our 
results suggested that samples containing 0.5% (w/w) of ZnO 
nanoparticles offered the lowest tensile modulus (p < 0.01). 
Increasing the ZnO nanoparticle concentration enhanced the 
tensile modulus of membranes to ≈10.5 MPa. We also evalu­
ated the degradation of the membranes under two different 
conditions: soaked in artificial saliva with a pH of 7.4, and in an 
alkaline environment at pH 8.5. This choice was due to the fact 
that in a nonhealing wound healing cascade the microenviron­
ment is shifted to a slight alkaline condition. Hence, we tested 
the degradability of the membranes in a representative alkaline 
solution. The results suggested that in the presence of ZnO par­
ticles, an increase in degradation rate was observed (p < 0.05, 
Figure 2e,f; Figure S2, Supporting Information). This slight 
increase might be due to the more hydrophilic nature of ZnO, 
which facilitated the water interaction with the polymeric mem­
branes and its hydrolysis. It should be noted that within 14 d, 
less than 4% mass loss was observed. The solution uptake was 
also assessed after 2 and 24 h in both artificial saliva and alka­
line solution (pH 8.5). The data suggested a higher uptake in an 
aqueous solution for membranes containing ZnO nanoparticles 
(Figure 2g,h; Figure S2, Supporting Information). This result is 
in agreement with the degradation profiles of the membranes.
We further investigated the function of the engineered peri­
odontal membranes in supporting cellular growth and differ­
entiation. Human periodontal ligament stem cells (PDLSCs) 
were isolated from periodontal tissues of patients with healthy 
periodontium as described in the Experimental Section. 
The cell seeded membranes were incubated in osteogenic 
differentiation media for 21 d. Cell proliferation analysis 
demon strated that increasing the concentration of ZnO par­
ticles from 0 to 1% (w/v) significantly decreased the number 
of viable cells (p < 0.05) in comparison to the pristine PCL 
membrane or the membrane containing 0.5% (w/v) of ZnO 
nanoparticles (Figure 3a). This observation could be related to 
the excessive H2O2 production by ZnO nanoparticles, causing 
high level of reactive oxygen species which was detrimental to 
cell function.[20] The alkaline phosphatase (ALP) activity of the 
seeded cells is presented in Figure 3b. PDLSCs on PCL with 
0.5% (w/v) ZnO exhibited the highest ALP activity (p < 0.05) 
at each tested time point. However, no statistically significant 
difference was observed in ALP activity values between the 
pristine PCL and the 1% (w/v) ZnO groups. The maximum 
amount of ALP activity for each group was reported after two 
weeks of culture.
Since our results described a statistical difference in viability 
in 1% (w/v) ZnO, we further investigated the potential effect of 
ZnO incorporated membranes on cellular mediated apoptosis 
in our tested cultures of PDLSCs. The immunofluorescence 
staining confirmed an increase expression of apoptotic marker 
Annexin V in the 1% (w/v) ZnO membrane (Figure 3c,d). How­
ever, there was no statistically significant difference between 
the culture of PDLSCs on pristine PCL and 0.5% (w/v) ZnO 
membranes.
After two­weeks of osteodifferentiation culture, the results 
of the Xylenol Orange (XO) staining revealed that PDLSCs 
seeded on the membrane with 0.5% (w/v) ZnO produced the 
greatest amounts of mineralized tissue (p < 0.05). However, 
no significant differences were found in the total mineral­
ized tissue as compared to pristine PCL and 1% (w/v) ZnO 
membranes (Figure 4a,b). Gene expression analysis was also 
Adv. Funct. Mater. 2018, 28, 1703437
Figure 3. In vitro studies on the engineered membrane. a) Cell proliferation analysis on the surface of PCL engineered membranes containing dif-
ferent concentrations of ZnO nanoparticles. b) Alkaline phosphatase (ALP) activity for PDLSCs seeded on the engineered membranes. The ALP value 
was normalized to the DNA concentration, with units of ngd-1/ug DNA. c,d) Qualitative and quantitative characterization of apoptotic seeded cells. 
*: p < 0.05, NS: not significant. Scale bar represents 200 µm.
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performed to evaluate the underlying molecular mechanism of 
the PDLSCs osteogenic differentiation. Several osteogenic dif­
ferentiation markers (e.g., Runx2 and osteocalcin (OCN)) were 
analyzed (Figure 4c). The data confirmed that PDLSCs seeded 
on 0.5% (w/v) ZnO membranes expressed significantly higher 
expression levels of Runx2 and OCN after two weeks of in vitro 
osteogenic induction, in comparison to PDLSCs seeded onto 
membranes containing 1% (w/v) ZnO.
The antibacterial activity of the engineered membrane 
was tested against Porphyromonas gingivalis ATCC 33277. 
P. gingivalis is a gram negative anaerobic bacterium commonly 
involved in inducing periodontitis.[21] We exposed the mem­
branes to different concentrations of bacteria culture and then 
assessed the number of colony forming units (CFUs) after 1 
and 5 d of culture. Obtained data (Figure 5) confirmed the pres­
ence of a significant antibacterial activity upon the incorpora­
tion of ZnO nanoparticles within the membranes. While pris­
tine PCL failed to exhibit any antibacterial activity after 1 and 
5 d of incubation, the membranes containing 0.5% (w/v) and 
1% (w/v) of ZnO nanoparticles presented significant antibacte­
rial properties at both time intervals (p < 0.05). Based on the 
promising in vitro experiments on P. gingivalis and PDLSCs, it 
can be concluded that 0.5% (w/v) of ZnO offered some level of 
antibacterial activity, while supporting the viability and the oste­
odifferentiation of seeded PDLSCs.
The in vitro data prompted us to evaluate the functionality 
of the engineered membrane through an animal model. To 
assess the function of the engineered nanofibrous membrane in 
healing of periodontal bone defect, we performed a pilot study 
using a rat periodontal defect model. Our in vitro experiments 
suggested a significant difference in the osteoconductivity of the 
engineered membranes containing ZnO nanoparticles. In addi­
tion, since the in vitro data suggested a better cytocompatibility 
of 0.5% (w/v) ZnO concentration, we only tested the membranes 
containing this concentration. A periodontal window defect of 
≈1.5 mm in width, 3 mm in length, and 2 mm in depth was cre­
ated in lingual of maxillary first molars in 6 rats. Subsequently, 
the animals were divided into two groups of 3 animals and each 
group received the following implants at the defect site: (1) sham 
(negative control) or (2) PCL membrane containing 0.5% ZnO 
(w/v). The process of implantation is shown in Figure 6a. Ani­
mals were sacrificed after 6 weeks and micro­computed tomog­
raphy (micro­CT) analysis was utilized to examine the amounts 
of bone regeneration. The vertical bone loss around the defect 
site was evaluated by measuring the distance between cement–
enamel junction (CEJ) and alveolar bone crest at three different 
points (mesiolingual (ML), mid lingual (L), and distolingual 
(DL)) on the lingual of the first maxillary molars. Representa­
tive micro­CT images before the formation of the defect and 
6 weeks after membrane implantation are presented in 
Figure 6b. All the specimens were standardized and micro­CT 
images were calibrated for proper comparative analysis. The 
semi­quantified analysis of the amounts of bone formation at 
the defect site after 6 weeks showed a smaller distance between 
the CEJ and the bone crest in the group that was subjected to 
the implantation of the engineered membrane containing 0.5% 
(w/v) ZnO nanoparticles. The results proved the effectiveness of 
the engineered membranes in bone regeneration related to peri­
odontitis. The location of the membrane is not apparent in these 
images. Further histological analysis is required for detained 
Adv. Funct. Mater. 2018, 28, 1703437
Figure 4. In vitro assessment of osteodifferentiation induced by the engineered membranes. a,b) Qualitative and quantitative measurement of oste-
odifferentiation of PDLSCs seeded on engineered PCL membranes containing different concentrations of ZnO nanoparticles, using XO staining after 
two weeks of culture in osteogenic media. Scale bar represents 200 µm. c) Expression level of osteogenic-related genes (Runx2 and OCN) after 2 
weeks of osteodifferentiation in vitro evaluated by real time-PCR. Data were normalized by the Ct of the housekeeping gene glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and expressed relatively to gene expression level at day 1 of culture. *: p < 0.05; NS: not significant.
www.afm-journal.dewww.advancedsciencenews.com
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Figure 6. Rat periodontal defect model. a) Depiction of rat periodontal defect design: mucoperiosteal flaps were elevated uncovering the alveolar 
bone adjacent to the lingual aspect of the first maxillary molar. The alveolar bone covering the root surfaces was removed with a dental bur, creating a 
periodontal window defect, and the periodontal membrane was placed into the defect site. b) Micro-CT analysis of the rat maxilla showing the control 
site, the defect site, and the defect size after application of the membrane. All the specimens were standardized and micro-CT images were calibrated 
for proper comparative analysis. c) Semi-quantitative analysis of the measurements (mm) from CEJ to the bone crest at each time interval (before and 
after defect, as well as after the membrane application). The transverse plane illustrates the defect and CEJ to bone crest distance. The location of the 
membrane is not apparent in these images. Further histological analysis is required for detained evaluation of the amounts of bone regeneration and 
periodontal repair. *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 5. Qualitative and quantitative characterization of the antibacterial properties of PCL engineered membranes containing different concentra-
tions of ZnO nanoparticles. a) Colony forming units (CFUs) of P. gingivalis colonies on the surface of the membranes. b) Quantified data on panel (a). 
*: p < 0.05, **: p < 0.01, and ***: p < 0.001.
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evaluation of the amounts of bone regeneration and periodontal 
repair.
Our in vitro data suggest that 0.5% (w/v) ZnO did not show 
any inhibitory effect on cell activity and function and demon­
strated enhanced cell osteodifferentiation in comparison to 
membranes containing 1% (w/v) ZnO. Our in vivo data also 
support the bone regenerative properties of the developed 
membranes containing 0.5% (w/v) ZnO via periodontal bone 
defect model in rats. However, identification of the optimal con­
centration requires further detailed animal studies. Altogether, 
our study demonstrated that the developed periodontal mem­
brane is a promising membrane for periodontal regeneration 
applications in vitro and in vivo.
3. Conclusions
The goal of this study was to develop a membrane that could 
be used for treatment of periodontal defects. Altogether, our 
findings confirmed that we successfully developed a bio­
degradable membrane with osteoconductive and antibacte­
rial properties, which can support GTR for the treatment of 
periodontitis­related bone loss. The fibrous membranes were 
fabricated via electrospinning of PCL­containing ZnO nano­
particles with tunable mechanical and degradation character­
istics. The membranes were flexible, easy to handle, and easy 
to implant. The results confirmed that incorporation of 0.5% 
(w/v) ZnO nanoparticles rendered the membranes antibacterial 
and osteoconductive responses, without negatively impacting 
their biocompatibility feature. We also demonstrated the in vivo 
functionality of the engineered membrane through a rat peri­
odontal defect model.
4. Experimental Section
Materials: All the chemicals including PCL with Mn = 80 000 and 
hexafluoroisopropanol were purchased from Sigma-Aldrich (St. Louis, 
MO) unless mentioned otherwise. The ZnO nanoparticles utilized 
in the study were provided by Functional Nanomaterials group at Kiel 
University, Germany.
Fabrication of Nanofibrous Membranes: The PCL-ZnO nanofibrous 
membranes were fabricated using a conventional electrospinning set-up. 
Briefly, PCL with Mn = 80 000 was dissolved in hexafluoroisopropanol 
to achieve a concentration of 10% (w/v). Then ZnO nanoparticles were 
dispersed in a bath sonicator for 10 min to obtain mixtures containing 
0.5 and 1% w/v ZnO particles within the PCL solution. The prepolymer 
solution was then transferred to a 3 mL syringe with a 20-G blunt needle 
tip used during the electrospinning process. An electrical field of ≈18 kV 
over a fixed spinning distance of 20 cm was applied. The flow rate of 
the prepolymer solution was set at 2 mL h−1, and the substrates were 
spun for 30 min to generate fibrous membranes, which have a thickness 
of ≈100 µm. Fibers were collected onto an aluminum flat collector to 
produce a sheet with uniform fiber distribution.
Optical and Elemental Analysis of Zinc Oxide Composites: The 
nanocomposite fiber morphology was investigated using a SEM (Zeiss 
Ultra Plus, 7 kV) with an EDX spectrometer. The nanocomposite 
fibers were sputtered with gold to reduce the surface charge then 
compositional analysis was performed in combination with SEM.
Mechanical Characterization of the Engineered Membranes: The 
mechanical properties of the prepared scaffolds were measured using 
a uniaxial tensile strength test with a universal mechanical testing 
machine (Instron 5542, Norwood, MA). Five samples of each membrane 
were tailored in rectangular-shaped (20 mm × 5 mm), positioned 
between two grips and subjected on tensile displacement. The constant 
crosshead speed was set at 10 mm min−1 and the related force was 
measured using a 10 N cell. The modulus of elasticity was calculated 
using the initial 0–10% liner region of the stress–strain curves for five 
samples and the mean values ± standard deviations were reported.
Swelling and Degradation Analysis: Fluid handling capacity was 
performed by soaking the dry membranes (1 cm × 1 cm) in 2 mL of 
NaOH based-solution (basic pH = 8.5) and separately in 2 mL of saliva 
mimicking solution containing 0.4 g L−1 KCl, 0.4 g L−1 NaCl, 0.906 g L−1 
CaCl2.2H2O, 0.690 g L−1 NaH2PO4.2H2O, 0.005 g L−1 Na2S.9H2O, and 
1 g L−1 urea.[22] The weight before and after 2 and 24 h of immersion in 
the solutions were measured with a high precision scale to assess the 
swelling ratio.
The degradation rate of the membranes was evaluated by 
placing square samples measuring 1 cm × 1 cm in 2 mL solution of 
artificial saliva (neutral pH = 7.5), and NaOH based-alkaline solution 
(basic pH = 8.5). The specimen weight was measured before the 
experiment and then after 1, 3, 7, and 14 d using a high precision scale.
In Vitro Assessment of Osteoconductivity of Membranes Containing ZnO 
Particles—Progenitor Cell Isolation and Culture: Teeth and PDL tissues 
were obtained from healthy male patients (18–25 years old) undergoing 
third molar extractions according to IRB approval. Subjects with a 
history of periodontal disease were excluded from this study. Human 
PDLSCs were isolated and cultured according to published protocols in 
the literature.[23]
Cell Seeding and Proliferation Analysis: All the fabricated disk-shaped 
membranes (PCL, PCL with 0.5% (w/v) ZnO or PCL with 1% (w/v) 
ZnO) were prewetted and sterilized in 70% ethanol for 2 h, washed 
with PBS, and soaked in a serum free culture medium overnight before 
cell seeding. PDLSCs were seeded onto the membranes at a density 
of 5 × 104 cells cm−2 and cultured in culture medium containing 
alpha-MEM with 15% FBS, 2 × 10−3 m l-glutamine, 100 × 10−9 m Dex, 
100 × 10−6 m ascorbic acid, 100 U mL−1 penicillin, and 100 µg mL−1 
streptomycin (Sigma, St. Louis, MO) for three weeks.
At different time intervals (1, 7, 14, and 21 d) the number of living 
cells was analyzed using Alamar Blue assay (Thermofischer). ALP 
activity was also determined based on previously published protocols.[24] 
Additionally, after two weeks of culture, apoptosis of the seeded MSCs 
was analyzed using FACSCalibur (BD Bioscience) flow cytometry by 
staining the cells with Annexin V-PE Apoptosis Detection Kit I (BD 
Bioscience). Additionally, the specimens were immunofluorescently 
stained using antibodies against Annexin V.
In Vitro Osteogenic Differentiation of PDLSCs: PDLSCs were 
seeded onto different fabricated membranes and cultured for two 
weeks. To induce osteogenesis, the specimens were placed in an 
osteogenic medium containing alpha-MEM, 10% FBS, 1% penicillin, 
streptomycin, and dexamethasone (0.1 × 10−3 m), beta-glycerophosphate 
(10 × 10−3 m), 1.8 × 10−3 m potassium dihydrogen phosphate, and 
ascorbic acid (50 mg mL−1).
After 2 weeks of culture in osteogenic differentiation medium, the 
samples were stained with Xylenol Orange (XO). The expression levels 
of Runx2 and ALP (Santa Cruz Biosciences, Dallas, TX) were assayed by 
PCR analysis.
In Vitro Assessment of Antibacterial Activity of Membranes Containing 
ZnO Particles: To evaluate the antibacterial activity and properties of 
the engineered membranes, PCL, PCL with 0.5% ZnO, and PCL with 
1% ZnO were tested against P. gingivalis (P.g.). P. gingivalis ATCC 33277 
was grown anaerobically (80% N2, 10% CO2, 10% H2) in Columbia 
Broth (CB) with hemin (5 µg mL−1) and menadione (1 µg mL−1) as 
supplements for 15–18 h. The culture was further adjusted to an optical 
density of 0.1 to be used in coincubation with the membrane samples.
Membranes were sectioned into 8 mm diameter discs with a biopsy 
punch in aseptic conditions. Five discs of each membrane type were 
tailored. The membrane discs were inoculated in 48 wells plate in 
1 mL 0.1 OD of P. gingivalis ATCC 33277 in CB with hemin (5 µg mL−1) 
and menadione (1 µg mL−1). One disc with CB alone served as negative 
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control. For the positive control, 0.1 OD of P.gingivalis was grown 
without the disc.
Subsequently, a direct inhibition of bacterial growth onto the 
membranes was performed by counting CFU after incubation for 1 and 
5 d at 37 °C in an anaerobic chamber. Aliquots of culture medium were 
then taken from each well, serially diluted, and placed on agar plates. 
The viability of P. gingivalis was analyzed on CB blood agar plates with 
hemin (5 µg mL−1) and menadione (1 µg mL−1) by spotting 20 µL of the 
serially diluted samples in CB (101 to 107). The colonies were counted 
after incubation of the plates in an anaerobic chamber for 3–5 d.
In Vivo Assessment of the Membrane Function: A rat periodontal defect 
model (Figure 6) was considered. Ten, two-month-old virgin male 
and female Spraguee Dawley rats (Harlan Laboratories, Livermore, 
CA) were utilized for testing the ZnO membrane in vivo. The test was 
performed according to approved protocols. Briefly, mucoperiosteal 
flaps were elevated uncovering the alveolar bone adjacent to the lingual 
aspect of the first maxillary molars. The alveolar bone covering the 
root surfaces on the lingual side was removed with a dental bur under 
saline irrigation. A periodontal window defect of ≈1.5 mm in width, 
3 mm in length, and 2 mm in depth was created. Subsequently, one of 
the following membranes was implanted into the defect site: (1) Sham, 
(2) PCL membrane, or (3) PCL membrane with 0.5% ZnO. Animals were 
sacrificed after 6 weeks and micro-CT analysis was used to examine the 
amounts of bone regeneration. The vertical bone loss around the defect 
site was evaluated by measuring the distance between CEJ and alveolar 
bone crest at three different points (mesiolingual (ML), mid lingual (L), 
and distolingual (DL)) on the lingual of the first maxillary molars.
Statistical Analysis: All measurements were made at least in triplicate, and 
data were presented as mean values ± standard deviation. One-way Anova 
test was performed and differences were considered statistically significant 
when p values resulted lower than 0.05: *p < 0.05, **p < 0.01, ***p < 0.001.
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